Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107


CD4 T-cell suppression by cells from Toxoplasma gondii-infected retinas is mediated by surface protein PD-L1.

Charles E, Joshi S, Ash JD, Fox BA, Farris AD, Bzik DJ, Lang ML, Blader IJ.

Infect Immun. 2010 Aug;78(8):3484-92. doi: 10.1128/IAI.00117-10. Epub 2010 May 24.


Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.

Ito T, Ueno T, Clarkson MR, Yuan X, Jurewicz MM, Yagita H, Azuma M, Sharpe AH, Auchincloss H Jr, Sayegh MH, Najafian N.

J Immunol. 2005 Jun 1;174(11):6648-56.


B7-1/2, but not PD-L1/2 molecules, are required on IL-10-treated tolerogenic DC and DC-derived exosomes for in vivo function.

Ruffner MA, Kim SH, Bianco NR, Francisco LM, Sharpe AH, Robbins PD.

Eur J Immunol. 2009 Nov;39(11):3084-90. doi: 10.1002/eji.200939407.


Tissue expression of PD-L1 mediates peripheral T cell tolerance.

Keir ME, Liang SC, Guleria I, Latchman YE, Qipo A, Albacker LA, Koulmanda M, Freeman GJ, Sayegh MH, Sharpe AH.

J Exp Med. 2006 Apr 17;203(4):883-95. Epub 2006 Apr 10.


CD4 T-cell help programs a change in CD8 T-cell function enabling effective long-term control of murine gammaherpesvirus 68: role of PD-1-PD-L1 interactions.

Dias P, Giannoni F, Lee LN, Han D, Yoon S, Yagita H, Azuma M, Sarawar SR.

J Virol. 2010 Aug;84(16):8241-9. doi: 10.1128/JVI.00784-10. Epub 2010 Jun 9.


T-cell suppression by programmed cell death 1 ligand 1 on retinal pigment epithelium during inflammatory conditions.

Sugita S, Usui Y, Horie S, Futagami Y, Aburatani H, Okazaki T, Honjo T, Takeuchi M, Mochizuki M.

Invest Ophthalmol Vis Sci. 2009 Jun;50(6):2862-70. doi: 10.1167/iovs.08-2846. Epub 2009 Jan 31.


Parasite Manipulation of the Invariant Chain and the Peptide Editor H2-DM Affects Major Histocompatibility Complex Class II Antigen Presentation during Toxoplasma gondii Infection.

Leroux LP, Nishi M, El-Hage S, Fox BA, Bzik DJ, Dzierszinski FS.

Infect Immun. 2015 Oct;83(10):3865-80. doi: 10.1128/IAI.00415-15. Epub 2015 Jul 20.


Secreted Toxoplasma gondii molecules interfere with expression of MHC-II in interferon gamma-activated macrophages.

Leroux LP, Dasanayake D, Rommereim LM, Fox BA, Bzik DJ, Jardim A, Dzierszinski FS.

Int J Parasitol. 2015 Apr;45(5):319-32. doi: 10.1016/j.ijpara.2015.01.003. Epub 2015 Feb 24.


Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation.

Kuipers H, Muskens F, Willart M, Hijdra D, van Assema FB, Coyle AJ, Hoogsteden HC, Lambrecht BN.

Eur J Immunol. 2006 Sep;36(9):2472-82.


PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells.

Waeckerle-Men Y, Starke A, Wüthrich RP.

Nephrol Dial Transplant. 2007 Jun;22(6):1527-36. Epub 2007 Mar 5.


Toxoplasma gondii inhibits MHC class II expression in neural antigen-presenting cells by down-regulating the class II transactivator CIITA.

Lüder CG, Lang C, Giraldo-Velasquez M, Algner M, Gerdes J, Gross U.

J Neuroimmunol. 2003 Jan;134(1-2):12-24.


Limited costimulatory molecule expression on renal tubular epithelial cells impairs T cell activation.

Waeckerle-Men Y, Starke A, Wahl PR, Wüthrich RP.

Kidney Blood Press Res. 2007;30(6):421-9. Epub 2007 Oct 26.


Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice.

Gotsman I, Grabie N, Dacosta R, Sukhova G, Sharpe A, Lichtman AH.

J Clin Invest. 2007 Oct;117(10):2974-82.


Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production.

Yamazaki T, Akiba H, Koyanagi A, Azuma M, Yagita H, Okumura K.

J Immunol. 2005 Aug 1;175(3):1586-92.


Diverse mechanisms employed by Toxoplasma gondii to inhibit IFN-gamma-induced major histocompatibility complex class II gene expression.

Lang C, Algner M, Beinert N, Gross U, Lüder CG.

Microbes Infect. 2006 Jul;8(8):1994-2005. Epub 2006 Jun 12.


Supplemental Content

Support Center